Zdrowie i gospodarka · 03/02/2006

FDA Clears Way for Gatifloxacin Injection Approval

The FDA has ruled that TEQUIN (gatifloxacin) injection, 10 mg/mL (200 mg), was not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of abbreviated new drug applications (ANDAs) for this medication.